top of page
Search

UK Immune Cell Therapy Biotech Founded with €40M Series A

  • Writer: agbiopro
    agbiopro
  • May 30, 2019
  • 1 min read

Updated: Jun 7, 2019

Quell Therapeutics, a London-based biotech developing immune cell therapies to target transplant rejection and autoimmune and inflammatory diseases.


Comments

bottom of page